Roche: Positive results in phase II for etrolizumab in Ulcerative Colitis

NEUTRAL, Fair Value CHF254 (+3%)

News published on May Monday 20, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities